Hypertension in Heart Failure With Reduced Ejection Fraction: Cause or Disease Modifier?

Authors

Maria Giulia Bellicini

Published in

Hypertension research : official journal of the Japanese Society of Hypertension. Oct 06, 2026. Epub Oct 06, 2026.

Abstract

The coexistence of hypertension and HFrEF should be distinguished from a causal progression from hypertensive heart disease to systolic heart failure. Available experimental, longitudinal, and clinical evidence does not consistently demonstrate such a transition in the absence of additional non hypertensive myocardial injury. In this context, the intriguing association reported by Harada et al. between changes in serum adiponectin and improvement in left ventricular ejection fraction specifically in patients with HFrEF and hypertension may identify hypertension as a modifier of the metabolic and inflammatory response of the failing myocardium rather than as the primary cause of systolic dysfunction. (see graphical abstract).

PMID:
42838971
Bibliographic data and abstract were imported from PubMed on 07 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.